FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 354:1095-1096 March 9, 2006 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Cohen, H. T.

To the Editor: The review of renal-cell carcinoma by Cohen and McGovern (Dec. 8 issue)¹ was extensive but did not discuss radiotherapy. As noted in the article, nearly half the patients with renal-cell carcinoma have metastatic disease on presentation or will have a recurrence. Conventional radiotherapy has been an effective palliative treatment for most sites of metastatic renal-cell carcinoma, including lung, bone, and soft tissues.² In particular, stereotactic radiosurgery has been reported to have local control rates for brain metastases of more than 85 percent.³ Recently, stereotactic radiosurgery for spinal metastases has demonstrated high efficacy in pain relief with minimal . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.